Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuhiro Ishida

Showing results (41-50 of 233) with videos related to

Pageof 24
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2004
Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in miceTatsuhiro Ishida, Takako Ichikawa, Masako Ichihara, et al.
Biological & Pharmaceutical Bulletin|April 2, 2005
Increased gene expression by cationic liposomes (TFL-3) in lung metastases following intravenous injectionWenhao Li, Tatsuhiro Ishida, Yurie Okada, et al.
International Journal of Pharmaceutics|January 9, 2025
An in vitro nanocarrier-based B cell antigen loading system; tumor growth suppression via transfusion of the antigen-loaded B cells in vivoYoshino Kawaguchi, Taro Shimizu, Haruka Takata, et al.
International Journal of Pharmaceutics|November 24, 2012
Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: promise for clinical applicationAi Nagao, Amr S Abu Lila, Tatsuhiro Ishida, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 13, 2011
Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNATatsuaki Tagami, Yumi Uehara, Naoto Moriyoshi, et al.
International Journal of Pharmaceutics|January 16, 2002
Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomesTatsuhiro Ishida, Yoshihiro Takanashi, Hisako Doi, et al.
Biological & Pharmaceutical Bulletin|July 5, 2022
Development of a Nanocarrier-Based Splenic B Cell-Targeting System for Loading Antigens in VitroYoshino Kawaguchi, Taro Shimizu, Hidenori Ando, et al.
Biological & Pharmaceutical Bulletin|February 3, 2016
Hepatic Tumor Metastases Cause Enhanced PEGylated Liposome Uptake by Kupffer CellsMasami Ukawa, Yukako Fujiwara, Hidenori Ando, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 15, 2003
Accelerated clearance of PEGylated liposomes in rats after repeated injectionsTatsuhiro Ishida, Ryuhei Maeda, Masako Ichihara, et al.
Journal of Pharmaceutical Sciences|December 19, 2013
Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid deliveryAmr S Abu Lila, Yumi Uehara, Tatsuhiro Ishida, et al.
Pageof 24

Showing results (41-50 of 233) with videos related to

Sort By:
Pageof 24
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 17, 2004
Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in miceTatsuhiro Ishida, Takako Ichikawa, Masako Ichihara, et al.
Biological & Pharmaceutical Bulletin|April 2, 2005
Increased gene expression by cationic liposomes (TFL-3) in lung metastases following intravenous injectionWenhao Li, Tatsuhiro Ishida, Yurie Okada, et al.
International Journal of Pharmaceutics|January 9, 2025
An in vitro nanocarrier-based B cell antigen loading system; tumor growth suppression via transfusion of the antigen-loaded B cells in vivoYoshino Kawaguchi, Taro Shimizu, Haruka Takata, et al.
International Journal of Pharmaceutics|November 24, 2012
Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: promise for clinical applicationAi Nagao, Amr S Abu Lila, Tatsuhiro Ishida, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 13, 2011
Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNATatsuaki Tagami, Yumi Uehara, Naoto Moriyoshi, et al.
International Journal of Pharmaceutics|January 16, 2002
Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomesTatsuhiro Ishida, Yoshihiro Takanashi, Hisako Doi, et al.
Biological & Pharmaceutical Bulletin|July 5, 2022
Development of a Nanocarrier-Based Splenic B Cell-Targeting System for Loading Antigens in VitroYoshino Kawaguchi, Taro Shimizu, Hidenori Ando, et al.
Biological & Pharmaceutical Bulletin|February 3, 2016
Hepatic Tumor Metastases Cause Enhanced PEGylated Liposome Uptake by Kupffer CellsMasami Ukawa, Yukako Fujiwara, Hidenori Ando, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 15, 2003
Accelerated clearance of PEGylated liposomes in rats after repeated injectionsTatsuhiro Ishida, Ryuhei Maeda, Masako Ichihara, et al.
Journal of Pharmaceutical Sciences|December 19, 2013
Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid deliveryAmr S Abu Lila, Yumi Uehara, Tatsuhiro Ishida, et al.
Pageof 24